Status:
WITHDRAWN
Use of the INAMED LAPBAND System to Reduce BMI's in Obese Renal Failure Patients
Lead Sponsor:
Summa Health System
Conditions:
Renal Failure
Obesity
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess the use of this Lap-Band system for the purpose of promoting weight loss in renal failure patients who do not qualify as transplant candidates because of excessi...
Detailed Description
The concern of transplant surgeons is that obese patients with high BMI's are more likely to experience post-transplantation complications than age-matched recipients \[1\]. Nevertheless, the Summa tr...
Eligibility Criteria
Inclusion
- 18 or older
- Hemodialysis patient with BMI between 36 and 42
Exclusion
- Patients undergoing peritoneal dialysis
Key Trial Info
Start Date :
October 17 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 24 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00466882
Start Date
October 17 2005
End Date
January 24 2011
Last Update
November 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Summa Health System
Akron, Ohio, United States, 44304